Eur. J. Immunol. 2008. 38: 1677–1688 10 Romagnoli, P., Hudrisier, D. and van Meerwijk, J. P., Preferential recognition of self antigens despite normal thymic deletion of CD4(+)CD25(+) regulatory T cells. J. Immunol. 2002. 168: 1644–1648. 11 Blazar, B. R., Taylor, P. A., Noelle, R. J. and Vallera, D. A., CD4(+) T cells tolerized ex vivo to host alloantigen by anti-CD40 ligand (CD40L:CD154) antibody lose their graft-versus-host disease lethality capacity but retain nominal antigen responses. J. Clin. Invest. 1998. 102: 473–482. 12 Chai, J. G., Bartok, I., Chandler, P., Vendetti, S., Antoniou, A., Dyson, J. and Lechler, R., Anergic T cells act as suppressor cells in vitro and in vivo. Eur. J. Immunol. 1999. 29: 686–692. 13 Chen, T. C., Cobbold, S. P., Fairchild, P. J. and Waldmann, H., Generation of anergic and regulatory T cells following prolonged exposure to a harmless antigen. J. Immunol. 2004. 172: 5900–5907. 14 Cobbold, S. P., Castejon, R., Adams, E., Zelenika, D., Graca, L., Humm, S. and Waldmann, H., Induction of foxP3+ regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants. J. Immunol. 2004. 172: 6003–6010. 15 Grundstrom, S., Cederbom, L., Sundstedt, A., Scheipers, P. and Ivars, F., Superantigen-induced regulatory T cells display different suppressive functions in the presence or absence of natural CD4+CD25+ regulatory T cells in vivo. J. Immunol. 2003. 170: 5008–5017. 16 Hara, M., Kingsley, C. I., Niimi, M., Read, S., Turvey, S. E., Bushell, A. R., Morris, P. J. et al., IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J. Immunol. 2001. 166: 3789–3796. 17 Kretschmer, K., Apostolou, I., Hawiger, D., Khazaie, K., Nussenzweig, M. C. and von Boehmer, H., Inducing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol. 2005. 6: 1219–1227. 18 Lee, R. S., Rusche, J. R., Maloney, M. E., Sachs, D. H., Sayegh, M. H. and Madsen, J. C., CTLA4Ig-induced linked regulation of allogeneic T cell responses. J. Immunol. 2001. 166: 1572–1582. 19 Vermeiren, J., Ceuppens, J. L., Van Ghelue, M., Witters, P., Bullens, D., Mages, H. W., Kroczek, R. A. and Van Gool, S. W., Human T cell activation by costimulatory signal-deficient allogeneic cells induces inducible costi- mulator-expressing anergic T cells with regulatory cell activity. J. Immunol. 2004. 172: 5371–5378. 20 Barrat, F. J., Cua, D. J., Boonstra, A., Richards, D. F., Crain, C., Savelkoul, H. F., de Waal-Malefyt, R. et al., In vitro generation of interleukin 10- producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J. Exp. Med. 2002. 195: 603–616. 21 Groux, H., O'Garra, A., Bigler, M., Rouleau, M., Antonenko, S., de Vries, J. E. and Roncarolo, M. G., A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997. 389: 737–742. 22 Zheng, S. G., Wang, J. H., Koss, M. N., Quismorio, F., Jr., Gray, J. D. and Horwitz, D. A., CD4+ and CD8+ regulatory T cells generated ex vivo with IL-2 and TGF-beta suppress a stimulatory graft-versus-host disease with a lupus-like syndrome. J. Immunol. 2004. 172: 1531–1539. 23 Kingsley, C. I., Karim, M., Bushell, A. R. and Wood, K. J., CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J. Immunol. 2002. 168: 1080–1086. 24 Niimi, M., Ikeda, Y., Shirasugi, N., Shatari, T., Takami, H., Kodaira, S., Matsumoto, K. et al., Oral delivery of alloantigen combined with non- depleting anti-CD4 monoclonal antibody induces indefinite survival of cardiac allografts and generates CD4(+) regulatory T cells. Transplant. Proc. 2000. 32: 2035. 25 Saitovitch, D., Bushell, A., Mabbs, D. W., Morris, P. J. and Wood, K. J., Kinetics of induction of transplantation tolerance with a nondepleting anti- CD4 monoclonal antibody and donor-specific transfusion before transplan- Immunomodulation 1687 tation. A critical period of time is required for development of immunological unresponsiveness. Transplantation 1996. 61: 1642–1647. 26 Hamano, K., Rawsthorne, M. A., Bushell, A. R., Morris, P. J. and Wood, K. J., Evidence that the continued presence of the organ graft and not peripheral donor microchimerism is essential for maintenance of tolerance to alloantigen in vivo in anti-CD4 treated recipients. Transplantation 1996. 62: 856–860. 27 Karim, M., Feng, G., Wood, K. J. and Bushell, A. R., CD25+CD4+ regulatory T cells generated by exposure to a model protein antigen prevent allograft rejection: antigen-specific reactivation in vivo is critical for bystander regulation. Blood 2005. 105: 4871–4877. 28 Thornton, A. M. and Shevach, E. M., Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific. J. Immunol. 2000. 164: 183–190. 29 Yamazaki, S., Patel, M., Harper, A., Bonito, A., Fukuyama, H., Pack, M., Tarbell, K. V. et al., Effective expansion of alloantigen-specific Foxp3+ CD25+ CD4+ regulatory T cells by dendritic cells during the mixed leukocyte reaction. Proc. Natl. Acad. Sci. USA 2006. 103: 2758–2763. 30 Bacchetta, R., Sartirana, C., Levings, M. K., Bordignon, C., Narula, S. and Roncarolo, M. G., Growth and expansion of human T regulatory type 1 cells are independent from TCR activation but require exogenous cytokines. Eur. J. Immunol. 2002. 32: 2237–2245. 31 Koenen, H. J., Fasse, E. and Joosten, I., IL-15 and cognate antigen successfully expand de novo-induced human antigen-specific regulatory CD4+ T cells that require antigen-specific activation for suppression. J. Immunol. 2003. 171: 6431–6441. 32 Rosen, S. D., Ligands for L-selectin: homing, inflammation, and beyond. Annu. Rev. Immunol. 2004. 22: 129–156. 33 Bai, Y., Liu, J., Wang, Y., Honig, S., Qin, L., Boros, P. and Bromberg, J. S., L-selectin-dependent lymphoid occupancy is required to induce alloantigen- specific tolerance. J. Immunol. 2002. 168: 1579–1589. 34 Ermann, J., Hoffmann, P., Edinger, M., Dutt, S., Blankenberg, F. G., Higgins, J. P., Negrin, R. S. et al., Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD. Blood 2005. 105: 2220–2226. 35 Fu, S., Yopp, A. C., Mao, X., Chen, D., Zhang, N., Chen, D., Mao, M., Ding, Y. and Bromberg, J. S., CD4+ CD25+ CD62+ T-regulatory cell subset has optimal suppressive and proliferative potential. Am. J. Transplant. 2004. 4: 65–78. 36 Szanya, V., Ermann, J., Taylor, C., Holness, C. and Fathman, C. G., The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7. J. Immunol. 2002. 169: 2461–2465. 37 You, S., Slehoffer, G., Barriot, S., Bach, J. F. and Chatenoud, L., Unique role of CD4+CD62L+ regulatory T cells in the control of autoimmune diabetes in T cell receptor transgenic mice. Proc. Natl. Acad. Sci. USA 2004. 101 Suppl 2: 14580–14585. 38 Fontenot, J. D., Gavin, M. A. and Rudensky, A. Y., Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 2003. 4: 330–336. 39 Hori, S., Nomura, T. and Sakaguchi, S., Control of regulatory T cell development by the transcription factor Foxp3. Science 2003. 299: 1057–1061. 40 Taylor, P. A., Panoskaltsis-Mortari, A., Swedin, J. M., Lucas, P. J., Gress, R. E., Levine, B. L., June, C. H. et al., L-Selectin(hi) but not the L-selectin(lo) CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection. Blood 2004. 104: 3804–3812. f 2008 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.eji-journal.eu